We are live on
!
Find out more
ED
Exane Derivatives Portfolio holdings
AUM
$174M
1-Year Est. Return
7.84%
This Fund
S&P 500
This Quarter
Est. Return
+2.15%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$466M
AUM Growth
+$23.6M
(+5.3%)
Cap. Flow
-$35.7M
Cap. Flow
% of AUM
-7.66%
Top 10 Holdings %
Top 10 Hldgs %
39.12%
Holding
698
New
128
Increased
157
Reduced
205
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$7.93M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$7.4M |
| 3 |
Stellantis
STLA
|
+$6.45M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$6.05M |
| 5 |
WIX.com
WIX
|
+$4.78M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RSX
VanEck Russia ETF
RSX
|
+$15M |
| 2 |
iShares MSCI Taiwan ETF
EWT
|
+$11.5M |
| 3 |
Vale
VALE
|
+$9.09M |
| 4 |
United States Oil Fund
USO
|
+$7.39M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$7.31M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.28% |
| 2 | Financials | 12.82% |
| 3 | Consumer Discretionary | 7.26% |
| 4 | Technology | 6.75% |
| 5 | Consumer Staples | 5.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Tesla
TSLA
$1.41T
| $3.77M | 0.81% |
156,135
+58,320
| +60% | +$1.28M |
|
|
27
CALL
Stellantis
STLA
$14.8B
| $3.53M | 0.76% |
3,255
-959
| -23% | -$10.2K |
|
|
28
PUT
Stellantis
STLA
$14.8B
| $3.53M | 0.76% |
5,337
-1,616
| -23% | -$17.2K |
|
29
Abercrombie & Fitch
ANF
$5.74B
| $3.05M | 0.65% |
245,194
+792
| +0.3% | +$9.76K |
|
30
AbbVie
ABBV
$465B
| $2.94M | 0.63% |
40,509
-12,571
| -24% | -$845K |
|
31
AB InBev
BUD
$156B
| $2.93M | 0.63% |
26,564
-21,070
| -44% | -$2.41M |
|
32
Alphabet (Google) Class A
GOOGL
$4.22T
| $2.8M | 0.6% |
60,160
+12,760
| +27% | +$597K |
|
33
Rogers Communications
RCI
$19.4B
| $2.76M | 0.59% |
+58,300
| New | +$2.69M |
|
34
ProShares S&P 500 Dividend Aristocrats ETF
NOBL
$11.4B
| $2.61M | 0.56% |
+90,286
| New | +$2.58M |
|
35
Darden Restaurants
DRI
$23.7B
| $2.59M | 0.56% |
28,604
-12,659
| -31% | -$1.11M |
|
36
State Street SPDR S&P 500 ETF Trust
SPY
$799B
| $2.5M | 0.54% |
+10,354
| New | +$2.48M |
|
37
Philip Morris
PM
$303B
| $2.5M | 0.54% |
+21,251
| New | +$2.46M |
|
38
H&R Block
HRB
$5.65B
| $2.48M | 0.53% |
+80,323
| New | +$2.11M |
|
39
iShares MSCI Peru and Global Exposure ETF
EPU
$544M
| $2.47M | 0.53% |
72,940
-40,861
| -36% | -$1.39M |
|
40
Eastman Chemical
EMN
$7.53B
| $2.39M | 0.51% |
28,455
+28,450
| +569,000% | +$2.29M |
|
41
Prologis
PLD
$129B
| $2.37M | 0.51% |
+40,398
| New | +$2.25M |
|
42
Masco
MAS
$13.6B
| $2.36M | 0.51% |
61,773
+60,938
| +7,298% | +$2.23M |
|
43
Applied Materials
AMAT
$334B
| $2.29M | 0.49% |
55,440
-21,247
| -28% | -$903K |
|
44
Capri Holdings
CPRI
$1.6B
| $2.28M | 0.49% |
+62,891
| New | +$2.28M |
|
45
HCA Healthcare
HCA
$91.8B
| $2.27M | 0.49% |
26,094
-5,228
| -17% | -$442K |
|
46
Aramark
ARMK
$15.4B
| $2.26M | 0.49% |
+76,518
| New | +$2.1M |
|
47
Bank of Montreal
BMO
$121B
| $2.24M | 0.48% |
30,475
-500
| -2% | -$35.4K |
|
48
Fortune Brands Innovations
FBIN
$4.77B
| $2.24M | 0.48% |
40,152
+39,582
| +6,944% | +$2.14M |
|
49
Stanley Black & Decker
SWK
$13.4B
| $2.19M | 0.47% |
15,536
+15,535
| +1,553,500% | +$2.13M |
|
50
Nike
NKE
$53.7B
| $2.18M | 0.47% |
36,923
+4,330
| +13% | +$234K |
|
Similar funds
PC
TWMP
LPWM
ACM
HWIS
LWM
EW
GDWAM
Exane Derivatives's Q2 2017 Portfolio in Review
As of Q2 2017, Exane Derivatives held 698 positions worth $466M, up 5.3% from $442M the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Exane Derivatives withdrew a net $35.7M in Q2 2017, closing 67 positions and reducing 205 holdings. Its most notable exit was Deutsche Bank Aktiengesellschaft, an estimated $6.91M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 39% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Exane Derivatives opened a new position in UBS Group worth $8.27M.
- Exane Derivatives's largest Q2 2017 buy was UBS Group: 487,870 shares worth $8.27M.
- Exane Derivatives added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $7.4M increase.
- Exane Derivatives's biggest Q2 2017 reduction was VanEck Russia ETF, cutting an estimated $15M.
- Exane Derivatives fully exited Deutsche Bank Aktiengesellschaft in Q2 2017, selling an estimated $6.91M.
- Exane Derivatives's ten largest holdings make up 39% of its $466M portfolio in Q2 2017.
- Exane Derivatives opened 128 new positions and closed 67 in Q2 2017.
- Exane Derivatives's portfolio value rose 5.3% quarter-over-quarter to $466M.
Based on Exane Derivatives's 13F filing for Q2 2017, filed 17 Jul 2017.